SAPHNELO Data: Remission Is An Achievable Goal

November 9, 2023 – SAPHNELO data shows patients are more likely to achieve and sustain remission in systemic lupus erythematosus compared to standard therapy alone.

For more information, please visit https://www.astrazeneca-us.com/media/press-releases/2023/saphnelo-data-show-patients-are-more-likely-to-achieve-and-sustain-remission-in-systemic-lupus-erythematosus-compared-to-standard-therapy-alone.html

Lupus Blog Articles: Lupus lorem ipsum dolor sit amet est requiem deste natur.

Scientists say they have identified a root cause of lupus — one that could pave the way for new treatments

Read

Belimumab (Benlysta) Now Approved in Saskatchewan, Nova Scotia, and New Brunswick for Lupus Nephritis

Read

LIVING WITH LUPUS | Elizabeth L.

Read